CO86 Clinical Outcomes of Diabetic Macular Edema Patients Treated With Faricimab and Aflibercept: A Subcohort Analysis of 20/50 or Worse Visual Acuity Across Faricimab Phase 3 Clinical Trials
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.165
https://www.valueinhealthjournal.com/article/S1098-3015(22)02369-5/fulltext
Title :
CO86 Clinical Outcomes of Diabetic Macular Edema Patients Treated With Faricimab and Aflibercept: A Subcohort Analysis of 20/50 or Worse Visual Acuity Across Faricimab Phase 3 Clinical Trials
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02369-5&doi=10.1016/j.jval.2022.09.165
First page :
Section Title :
Open access? :
No
Section Order :
11233